New concussion program aims at treating football players with predisposition to CTE

Upledger Institute Clinic in conjunction with the Ricky Williams Foundation and the Dr. John E. Upledger Foundation announced earlier today, the start of their second concussion therapy research program aimed at treating current and former members of the NFL and the Canadian Football League.

Designed for football players with a predisposition to Chronic Traumatic Encephalopathy (CTE), the five-day intensive clinical program begins on Sept 25th at the headquarters of Upledger Institute International in Palm Beach Gardens, Florida. The intensive manual therapy program utilizes CranioSacral Therapy, Visceral Manipulation, Neural Manipulation and other healing modalities aimed at helping the body heal itself.

CranioSacral Therapy is a gentle, hands-on treatment modality that releases tensions deep in the body to relieve pain and dysfunction and improve whole-body health and performance. Developed by Osteopathic Physician John E. Upledger, therapists focus upon the removal of restrictive forces within the membrane system surrounding the surface of the brain, the bones of the skull and vertebral column, including the sacrum and coccyx.

The objective of this study is to demonstrate that advanced therapies administered by certified, licensed manual therapists will help to alleviate the symptoms of post concussion syndrome.

Ricky Williams, who played professional football for 12 seasons and suffered repeated trauma to his head and body during his career, strongly supports this program. In describing his best year as a player, Williams said, "Right before Summer Camp, I went through the CranioSacral Intensive Program. I credit my wellbeing and my best season ever to the multi-modality manual therapy program I experienced at Upledger."

Source:

Upledger Institute Clinic

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
COVID-19 vaccine effectiveness barely affected by Delta variant, research suggests